A detailed history of Parallel Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 108,805 shares of ABBV stock, worth $19.6 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
108,805
Previous 110,107 1.18%
Holding current value
$19.6 Million
Previous $18.9 Million 13.77%
% of portfolio
0.51%
Previous 0.49%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $213,319 - $259,527
-1,302 Reduced 1.18%
108,805 $21.5 Million
Q2 2024

Aug 08, 2024

SELL
$154.79 - $180.76 $207,418 - $242,218
-1,340 Reduced 1.2%
110,107 $18.9 Million
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $166,692 - $189,930
1,043 Added 0.94%
111,447 $20.3 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $241,488 - $271,972
-1,755 Reduced 1.56%
110,404 $17.1 Million
Q3 2023

May 20, 2024

BUY
$133.59 - $154.65 $221,625 - $256,564
1,659 Added 1.5%
112,159 $16.7 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $221,625 - $256,564
1,659 Added 1.5%
112,159 $16.7 Million
Q2 2023

May 20, 2024

SELL
$132.51 - $164.9 $174,250 - $216,843
-1,315 Reduced 1.18%
110,500 $14.9 Million
Q2 2023

Aug 04, 2023

SELL
$132.51 - $164.9 $174,250 - $216,843
-1,315 Reduced 1.18%
110,500 $14.9 Million
Q1 2023

May 20, 2024

BUY
$144.61 - $166.54 $53,216 - $61,286
368 Added 0.33%
111,815 $17.8 Million
Q1 2023

Apr 25, 2023

BUY
$144.61 - $166.54 $10.9 Million - $12.5 Million
75,111 Added 204.64%
111,815 $17.8 Million
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $457,391 - $548,532
3,307 Added 9.9%
36,704 $5.94 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $340,490 - $390,520
2,537 Added 8.22%
33,397 $4.48 Million
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $57,800 - $73,483
-420 Reduced 1.34%
30,860 $4.73 Million
Q1 2022

Apr 28, 2022

SELL
$131.98 - $163.75 $42,497 - $52,727
-322 Reduced 1.02%
31,280 $5.12 Million
Q4 2021

Jan 20, 2022

BUY
$107.43 - $135.93 $350,544 - $443,539
3,263 Added 11.51%
31,602 $4.28 Million
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $19,896 - $22,585
187 Added 0.66%
28,339 $3.06 Million
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $330,043 - $367,687
3,137 Added 12.54%
28,152 $3.17 Million
Q1 2021

Apr 23, 2021

BUY
$102.3 - $112.62 $131,660 - $144,941
1,287 Added 5.42%
25,015 $2.71 Million
Q4 2020

Feb 02, 2021

SELL
$80.49 - $108.67 $124,679 - $168,329
-1,549 Reduced 6.13%
23,728 $2.54 Million
Q3 2020

Oct 27, 2020

BUY
$85.91 - $100.83 $69,157 - $81,168
805 Added 3.29%
25,277 $2.21 Million
Q2 2020

Jul 16, 2020

BUY
$73.37 - $98.18 $134,046 - $179,374
1,827 Added 8.07%
24,472 $2.4 Million
Q1 2020

Apr 27, 2020

BUY
$64.5 - $97.79 $838 - $1,271
13 Added 0.06%
22,645 $1.73 Million
Q4 2019

Jan 30, 2020

BUY
$72.13 - $90.25 $6,996 - $8,754
97 Added 0.43%
22,632 $2 Million
Q3 2019

Nov 01, 2019

SELL
$62.98 - $75.72 $401,875 - $483,169
-6,381 Reduced 22.07%
22,535 $1.71 Million
Q2 2019

Aug 05, 2019

BUY
$65.7 - $83.98 $208,071 - $265,964
3,167 Added 12.3%
28,916 $2.1 Million
Q1 2019

May 01, 2019

SELL
$77.14 - $90.79 $34,018 - $40,038
-441 Reduced 1.68%
25,749 $2.08 Million
Q4 2018

Feb 05, 2019

BUY
$77.85 - $96.01 $57,297 - $70,663
736 Added 2.89%
26,190 $2.41 Million
Q3 2018

Nov 01, 2018

BUY
$88.91 - $98.84 $388,447 - $431,831
4,369 Added 20.72%
25,454 $2.41 Million
Q2 2018

Jul 30, 2018

BUY
$89.78 - $106.23 $415,052 - $491,101
4,623 Added 28.08%
21,085 $1.95 Million
Q1 2018

May 08, 2018

BUY
$92.01 - $123.21 $14,077 - $18,851
153 Added 0.94%
16,462 $1.56 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $33,674 - $36,926
-376 Reduced 2.25%
16,309 $1.58 Million
Q3 2017

Nov 15, 2017

BUY
$69.85 - $89.22 $1.17 Million - $1.49 Million
16,685 New
16,685 $1.59 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $1.19 Million - $1.52 Million
-17,077 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
17,077
17,077 $1.19 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.